首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   377627篇
  免费   44652篇
  国内免费   590篇
  2018年   3244篇
  2017年   3093篇
  2016年   4193篇
  2015年   5417篇
  2014年   6648篇
  2013年   8943篇
  2012年   10291篇
  2011年   10442篇
  2010年   6889篇
  2009年   6648篇
  2008年   9216篇
  2007年   9384篇
  2006年   9185篇
  2005年   8742篇
  2004年   8586篇
  2003年   8443篇
  2002年   8191篇
  2001年   23792篇
  2000年   23750篇
  1999年   18178篇
  1998年   5103篇
  1997年   5486篇
  1996年   5048篇
  1995年   4568篇
  1994年   4475篇
  1993年   4496篇
  1992年   13655篇
  1991年   13448篇
  1990年   12573篇
  1989年   12442篇
  1988年   11494篇
  1987年   10497篇
  1986年   9496篇
  1985年   9334篇
  1984年   7252篇
  1983年   6351篇
  1982年   4546篇
  1981年   3956篇
  1980年   3741篇
  1979年   6678篇
  1978年   5166篇
  1977年   4695篇
  1976年   4150篇
  1975年   4680篇
  1974年   4894篇
  1973年   4860篇
  1972年   4293篇
  1971年   4002篇
  1970年   3468篇
  1969年   3328篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Indirect evidence has suggested that the Msh2-Msh6 mispair-binding complex undergoes conformational changes upon binding of ATP and mispairs, resulting in the formation of Msh2-Msh6 sliding clamps and licensing the formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes. Here, we have studied eight mutant Msh2-Msh6 complexes with defective responses to nucleotide binding and/or mispair binding and used them to study the conformational changes required for sliding clamp formation and ternary complex assembly. ATP binding to the Msh6 nucleotide-binding site results in a conformational change that allows binding of ATP to the Msh2 nucleotide-binding site, although ATP binding to the two nucleotide-binding sites appears to be uncoupled in some mutant complexes. The formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes requires ATP binding to only the Msh6 nucleotide-binding site, whereas the formation of Msh2-Msh6 sliding clamps requires ATP binding to both the Msh2 and Msh6 nucleotide-binding sites. In addition, the properties of the different mutant complexes suggest that distinct conformational states mediated by communication between the Msh2 and Msh6 nucleotide-binding sites are required for the formation of ternary complexes and sliding clamps.  相似文献   
83.
84.
L-myo-Inositol-1-phosphate synthase has been found to have at least a 5-fold preference for the beta-anomer of its natural substrate D-Glc-6-P. The alpha-anomer appears to be an inhibitor of the reaction and may be converted to product as well. As well as showing an enzymatic preference for the equatorial C-1 hydroxyl of D-Glc-6-P, our results suggest that it is the pyranose form of D-Glc-6-P that binds to the enzyme and that ring-opening is an enzymatic step. We have also found D-2-dGlc-6-P, D-2-F-2-dGlc-6-P, and D-Man-6-P each to be both competitive inhibitors and substrates that are converted to inositol phosphates by the synthase. D-Allose-6-P is a weak inhibitor of the enzyme, but not a substrate. D-Gal-6-P is neither substrate nor inhibitor. Thus the specificity of the synthase with respect to single position epimers of D-Glc-6-P increases in the order C1 less than C2 much less than C3 less than C4.  相似文献   
85.
86.
87.
88.
Intraperitoneal stimulation of adoptively sensitized rats with bacterial antigen promotes the localization of lymphoblasts at the site of antigen deposition. Lymphoblast extravasation activity (LEA) is generated only when specifically immune donor lymphocytes and the recipients of these cells share at least on Ag-B haplotype. However, if the specificity criteria for its formation are satisfied, LEA promotes the local development of lymphoblasts of all available specificities and irrespective of their Ag-B genotype. Allogeneic lymphoblasts do not participate actively in the delayed inflammatory reaction even when they are passively recruited into exudates. The results suggest that LEA is a T cell-derived mediator that amplifies the delayed type hypersensitivity reaction by directing recently activated lymphocytes into lesions.  相似文献   
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号